Previous work has examined cross‐talk between IGF‐1R and EGFR signaling in HNSCC to show that IGF‐1R activation leads to EGFR inhibitor resistance26 and IGF‐1R inhibition results in compensatory activation of EGFR.49 Here, IGF1R is linked to head and neck squamous cell carcinoma.